ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1926

Effectiveness of the Making It Work™ Program at Improving Absenteeism in Workers with Inflammatory Arthritis – Results of a Randomized Controlled Trial

Andre Luquini1, Yufei Zheng2, Hui Xie2, Catherine L. Backman3, Pamela Rogers4, Alex Kwok4, Astrid Knight4, Monique Gignac5, Dianne Mosher6, Linda Li3, John Esdaile7, Carter Thorne8 and Diane Lacaille2, 1University of British Columbia / Arthritis Research Canada, Fort Saint John, BC, Canada, 2Arthritis Research Canada, Richmond, BC, Canada, 3University of British Columbia, Vancouver, BC, Canada, 4Arthritis Research Canada / UBC, Vancouver, BC, Canada, 5Institute for Work & Health, Toronto, ON, Canada, 6University of Calgary, Calgary, AB, Canada, 7Arthritis Research Canada, Vancouver, BC, Canada, 8Southlake Regional Health Centre, Newmarket, ON, Canada

Meeting: ACR Convergence 2021

Keywords: absenteeism, Employment, Randomized Trial, Sick leave, work

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Abstracts: Epidemiology & Public Health II: Inflammatory Arthritis (1923–1926)

Session Type: Abstract Session

Session Time: 4:15PM-4:30PM

Background/Purpose: Despite advances in treatment, absenteeism remains a major problem for workers living with inflammatory arthritis (IA), leading to reduced income and quality of life. Yet, health services addressing employment needs of people with arthritis are lacking. We evaluated the effectiveness of the Making-it-WorkTM (MIW), an online program developed to help people with IA deal with employment issues, at preventing days missed from work and work interruptions.

Methods: A multi-center RCT evaluated the effectiveness of MIW at improving absenteeism over two years. Participants were recruited from rheumatologist practices, consumer organizations and arthritis programs, in three provinces. Eligibility criteria included: diagnosis of IA, being employed, age 18-59, and concerned about ability to work. Participants were randomized 1:1 to MIW or usual care plus printed material on workplace tips. MIW consists of five online self-learning modules and group meetings, and individual vocational counselling and ergonomic assessments. Questionnaires were administered every 6 months. Outcomes were 1) number of sick days (occasional days missed from work and sick leaves shorter than 2 months duration), calculated as a rate per 100 workable days; 2) work interruptions greater than 2 months duration, calculated per 100 days of follow-up, and 3) the combined outcome ( sum of sick days taken and work interruptions of any duration, calculated per 100 days of follow-up. Intention-to-treat analysis using Beta-binomial logistic regression models were used to evaluate the intervention effects on the three absenteeism outcomes, in separate analyses, accounting for the potential overdispersion in binomial outcomes. Odds ratios (OR) representing the intervention’s effect on the daily risk of each absenteeism outcome, adjusting for baseline characteristics [age, sex, education, ethnicity, job type, RA duration, pain, disease activity (RADAI), fatigue, and physical function (HAQII)], 95% confidence intervals and Wald-tests were computed using robust standard errors accounting for potential model mis-specifications. Analyses were conducted using STATA 16.

Results: A total of 564 participants were recruited, with 85% completing 2-year follow-up. Baseline characteristics were similar between groups (Table 1). Mean (SD) number of sick days were 2.7 (4.6) and 2.3 (4.3) per 100 workable days, for controls and MIW, respectively; and mean (SD) number of days of work interruptions were 10.5 (22) and 8.8 (21.2) per 100 days of follow-up, respectively. The intervention group had a 21% lower odds of taking sick days from work (p=0.028), a 30% lower odds of work interruptions (p=0.064), and a 26% lower odds of the combined outcome (sick days and work interruptions) (p=0.004) (Table 2).

Conclusion: Results of the RCT reveal that the program was effective at improving absenteeism by decreasing the odds of sick days, and work interruptions, although the latter was of borderline statistical significance. Effectiveness at preventing long-term work disability will be assessed at 5 years. This program fills one of the most important unmet needs for people with inflammatory arthritis.

Table 1. Baseline Characteristics

able 2. Beta binomial logistic regression model estimating the effect of the intervention on absenteeism


Disclosures: A. Luquini, None; Y. Zheng, None; H. Xie, None; C. Backman, None; P. Rogers, None; A. Kwok, None; A. Knight, None; M. Gignac, None; D. Mosher, None; L. Li, None; J. Esdaile, None; C. Thorne, AbbVie, 1, Amgen Inc, 1, Celgene, 1, Eli Lilly, 1, Medexus/Medac, 1, 2, 6, Merck, 1, 2, Novartis, 1, 5, Pfizer, 1, 5, Sandoz, 1, Sanofi, 1, Centocor, 2; D. Lacaille, None.

To cite this abstract in AMA style:

Luquini A, Zheng Y, Xie H, Backman C, Rogers P, Kwok A, Knight A, Gignac M, Mosher D, Li L, Esdaile J, Thorne C, Lacaille D. Effectiveness of the Making It Work™ Program at Improving Absenteeism in Workers with Inflammatory Arthritis – Results of a Randomized Controlled Trial [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/effectiveness-of-the-making-it-work-program-at-improving-absenteeism-in-workers-with-inflammatory-arthritis-results-of-a-randomized-controlled-trial/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effectiveness-of-the-making-it-work-program-at-improving-absenteeism-in-workers-with-inflammatory-arthritis-results-of-a-randomized-controlled-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology